Journalists: For links to video and audio files, see the bottom of this post.
Drug Shows Promise for Metastatic Colorectal Cancer Treatment
A new investigational drug called Regorafenib has been shown to shrink tumor size and improve overall survival in patients with metastatic colorectal cancer. Research was presented at the Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology by Axel Grothey, M.D. of Mayo Clinic.
News Release Regorafenib clinical trial2
Journalists: The following video and audio clips are available for download and use in your post-embargo stories.
Below is a link to an edited youtube video with Dr. Grothey that you can embed with your stories. It will be made public when the embargo lifts.